Showing results (281-290 of 290) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 290 results.
Proteins|November 2, 2016
Sense and simplicity in HADDOCK scoring: Lessons from CASP-CAPRI round 1A Vangone, J P G L M Rodrigues, L C Xue, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2013
Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinomaX Wu, P Y Huang, P J Peng, et al.
Genome Announcements|August 13, 2016
Genome Sequences of Gordonia Phages Hotorobo, Woes, and MontyWelkin H Pope, Jameson P Davis, Sirinya O'Shea, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 17, 2020
[Bivariate heritability estimation of resting heart rate and common chronic disease based on extended pedigrees]H C Zheng, E C Xue, X H Wang, et al.
Cell Death and Differentiation|November 24, 2012
The histone deacetylase SIRT2 stabilizes Myc oncoproteinsP Y Liu, N Xu, A Malyukova, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2012
Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinomaC Xue, Y Huang, P Y Huang, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|May 19, 2024
[Multicenter evaluation of the diagnostic efficacy of jaundice color card for neonatal hyperbilirubinemia]G C Xue, H L Zhang, X X Ding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2026
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumorsD Y Ruan, S Y Lin, J J Huang, et al.
Nature Medicine|January 8, 2013
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsAndrew J Souers, Joel D Leverson, Erwin R Boghaert, et al.
Pageof 29